584.SI

AJJ Medtech Holdings Limited
SESSGDEQUITY DELAYED
Last price
0.00
■ 0.00 (0.00%)
MARKET ·

Price

1D H L Range Vol
Drag pan · Pinch zoom · Hold crosshair · pick a tool then drag to draw
Open
Prev close
0.00
Day high
0.00
Day low
0.00
Volume
500
Market cap
P/E (TTM)
52W range
0.00 – 0.01

Trailing performance

Price return · vs SPY
Returnvs SPY
1W
0.00% +1.0%
1M
-20.00% -23.5%
3M
-20.00% -22.6%
6M
-42.86% -54.9%
YTD
-60.00% -72.2%
1Y
+33.33% +13.0%
3Y
-33.33% -108.6%
5Y

Price return only. Dividends are not reinvested, so total return on a dividend payer will be higher than shown.

Free account

6 more panels on 584.SI open with an account.

Options chains and analytics, valuation ratios, insider filings, analyst targets and ownership. No card, no trial, nothing to cancel.

Fundamentals

TTM · reported
Market cap
Enterprise value
Revenue (TTM)
Gross profit
EBITDA
Net income
EPS (TTM)
Free cash flow
Total cash
Total debt
Book value / share
Shares outstanding
Float
Short % of float
Dividend yield
Beta (5Y)

Valuation & profitability ratios

Account required
Trailing P/E
Forward P/E
PEG ratio
Price / sales
Price / book
EV / revenue
EV / EBITDA
Gross margin
Operating margin
Profit margin
Return on equity
Return on assets
Debt / equity
Current ratio
Free account required

Fourteen ratios including P/E, PEG, EV/EBITDA, margins and return on equity.

Financial statements

As reported · 4 years · 6 quarters
Blank means not reported, not zero
Line item2025202420232022YoY
Total revenue $3.19M$2.32M$1.61M$596.00K +37.4%
Operating revenue $3.19M$2.32M$1.61M$596.00K +37.4%
Cost of revenue $2.02M$1.74M$916.00K$284.00K +16.2%
Gross profit $1.18M$587.00K$699.00K$312.00K +100.2%
Selling, general & admin $4.11M$4.55M$3.27M$4.28M -9.6%
Total operating expense $4.05M$4.48M$3.21M$4.25M -9.6%
Operating income -$2.87M-$3.89M-$2.51M-$3.93M +26.2%
Net interest income -$87.00K-$54.00K-$59.00K-$57.00K -61.1%
Pre-tax income -$2.93M-$3.87M-$2.56M-$3.98M +24.3%
Tax provision $3.00K-$4.00K-$5.00K-$280.00K +175.0%
Net income -$2.93M-$3.87M-$2.53M-$4.24M +24.2%
Net income to common -$2.93M-$3.87M-$2.53M-$4.24M +24.2%
Basic EPS -0.00-0.00-0.00-0.00 +32.1%
Diluted EPS -0.00-0.00-0.00-0.00 +32.1%
EBIT -$2.84M-$3.81M-$2.50M-$3.93M +25.5%
EBITDA -$2.38M-$3.40M-$2.06M-$3.19M +30.1%
Basic shares 1.53B1.37B933.80M933.80M +11.9%
Diluted shares 1.53B1.37B933.80M933.80M +11.9%

Analyst targets & ownership

Account required
Mean target
High target
Low target
Implied upside
Analyst count
Consensus
Strong buy / Buy— / —
Hold
Sell / Strong sell— / —
Held by insiders
Held by institutions
Institutions holding
Free account required

Price targets, consensus spread, insider and institutional ownership.

Moving averages & technicals

Computed from 2Y daily closes
SMA 10
0.00
-9.09% from price
SMA 20
0.00
-10.11% from price
SMA 50
0.00
-9.50% from price
SMA 100
0.00
-18.70% from price
SMA 200
0.01
-42.28% from price
EMA 12
0.00
-8.04% from price
EMA 26
0.00
-9.64% from price
EMA 50
0.00
-12.48% from price
RSI (14)
45.5
Neutral
MACD (12,26,9)
-0.00
Hist -0.00
ATR (14)
0.00
23.21% of price
Realised vol 30D
226.7%
Annualised
Bollinger upper
0.01
20, 2σ
Bollinger lower
0.00
20, 2σ
50 / 200 cross
Death
0.00 vs 0.01
Trend bias
Below 200
-42.28%

Options chain

Account required
Expiry
Spot 0.00
Calls
StrikeLastBidAskVolOIIV
000.000.000.000.00000.0%
000.000.000.000.00000.0%
000.000.000.000.00000.0%
000.000.000.000.00000.0%
000.000.000.000.00000.0%
000.000.000.000.00000.0%
000.000.000.000.00000.0%
Puts
StrikeLastBidAskVolOIIV
000.000.000.000.00000.0%
000.000.000.000.00000.0%
000.000.000.000.00000.0%
000.000.000.000.00000.0%
000.000.000.000.00000.0%
000.000.000.000.00000.0%
000.000.000.000.00000.0%
Free account required

Every listed expiry, both sides of the book, with volume, open interest and implied volatility.

Risk profile

Daily returns · 1Y window
Beta vs SPY
-0.31
Less volatile than market
Correlation to SPY
-0.02
Largely independent
Realised vol 30D
226.7%
Annualised
Market vol 1Y
12.8%
SPY, annualised
Max drawdown 1Y
-75.0%
Peak to trough
Max drawdown 5Y
-92.9%
Peak to trough
ATR 14
0.00
23.21% of price
Beta (reported)
5Y monthly, from filing

PRIVATE STRATEGY · BY QUALIFICATION

The same data. A different seat.

The research you are reading is the input layer for a discretionary options program we run for a small number of qualified investors. Minimum $1,000,000.